With Oncomine^™ Research Premium Edition, you can:

Design better experiments...Answer more questions with fewer experiments, select the most promising gene or cell line, and test your hypothesis.

Gain more biological insights...Discover novel targets for therapeutic development, interrogate gene expression profiles, and identify drug and biological interactions.

Prepare to publish faster...Validate your results faster, visualize data easier and make connections to clinical significance.

The Oncomine^™ Platform—from web applications to translational bioinformatics services—provides solutions for individual researchers and multinational companies, with robust, peer-reviewed analysis methods and a powerful set of analysis functions that compute gene expression signatures, clusters and gene-set modules, automatically extracting biological insights from the data. It has become an industry-standard tool cited in more than 1,100 peer-reviewed journal articles. The Oncomine Platform has been used as a foundation for ground-breaking discoveries with unique features that include:

• Scalability — with 700+ independent datasets
• High quality — with expertly curated data
• Consistency — with a rich, extensive and controlled ontology of terms
• Standardized analysis — with conventions that assure clear and consistent interpretations of results

Oncomine Research Edition remains free to the academic and nonprofit cancer research communities.

Oncomine Research Premium Edition is a subscription version that includes compelling features such as multi-gene search, expanded analyses, custom concept upload, export capability and enhanced support. Click here for more information.

The Origin of the Oncomine Platform
The Oncomine Platform was conceived by physicians, scientists, and software engineers at the University of Michigan. It was commercialized by Arul Chinnaiyan and Dan Rhodes in February 2006 with the goal of building a version that would have a greater ability to impact drug development and clinical practice.